Finance

Lists
BRIBF:OTCMKTS
Brii Biosciences Ltd
0,13 $
0,00%
(0,00) 1D
5 там., 13:31:28 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BRIBF...
Mkt. cap
624,76 млн
Avg. vol.
0,00
Volume
0,00
52-wk high
0,19 $
52-wk low
0,13 $
Beta
-223,84
Shares outstanding
735,32 млн
No. of employees
80
Mkt. cap
624,76 млн
Avg. vol.
0,00
Volume
0,00
52-wk high
0,19 $
52-wk low
0,13 $
Beta
-223,84
Shares outstanding
735,32 млн
No. of employees
80
News stories
From web sources and news partners
About Brii Biosciences Ltd
CEO-
Employees80
Founded2017
Headquarters-
Sector-
Websitebriibio.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
17,28 млн
17,28 млн
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
47,94 млн
47,94 млн
49,17 млн
49,17 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
25,61 млн
25,61 млн
26,29 млн
26,29 млн
Operating expense
73,55 млн
73,55 млн
75,45 млн
75,45 млн
Total operating expenses
73,55 млн
73,55 млн
75,45 млн
75,45 млн
Operating income
-56,27 млн
-56,27 млн
-75,45 млн
-75,45 млн
Other non operating income
-209,00 м.
-209,00 м.
152,50 м.
152,50 м.
EBT including unusual items
-36,66 млн
-36,66 млн
-50,49 млн
-50,49 млн
EBT excluding unusual items
-40,83 млн
-40,83 млн
-65,41 млн
-65,41 млн
Income tax expense
950,00 м.
950,00 м.
-
-
Effective tax rate
-2,59%
-2,59%
-
-
Other operating expenses
-
-
-
-
Net income
-37,28 млн
-37,28 млн
-50,28 млн
-50,28 млн
Net profit margin
-215,76%
-215,76%
-
-
Earnings per share
-
-
-
-
Interest and investment income
12,20 млн
12,20 млн
9,61 млн
9,61 млн
Interest expense
-30,50 мың
-30,50 мың
-66,00 мың
-66,00 мың
Net interest expenses
12,17 млн
12,17 млн
9,54 млн
9,54 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-56,11 млн
-56,11 млн
-74,98 млн
-74,98 млн
Gain or loss from assets sale
204,00 м.
204,00 м.
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары